Tag Archives: VKTX

A Survivor Of The GLP-1 Massacre

The GLP-1 stock massacre of 2025 was brutal, indiscriminate, and thoroughly predictable. Viking Therapeutics (VKTX) got caught in the crossfire, dropping from its peak alongside every other obesity drug hopeful when the market decided a price war was imminent. I watched the selling cascade through the sector like an avalanche, taking down pre-revenue biotechs and […]

When The Longship Everyone Abandoned Sets Sail

Let me tell you about the worst day I’ve had watching a biotech stock in years. August 19, 2025. Viking Therapeutics (VKTX) reported its oral VK2735 data, and the stock dropped 40% before I could finish my morning coffee. My phone exploded with panicked messages from people who’d clearly only read the headlines. “High discontinuation […]